Robert Hershberg, Director at Adaptive Biotechnologies Corp (ADPT), sold 22,968 shares at $16.00 ($367K) on 2025-12-10, disclosed to the SEC on 2025-12-12.
Open-market sale of $367k ADPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2025-03-12 | $402K | — | Filing → |
| HLVX | SELL | 2025-02-12 | $49K | — | Filing → |
| HLVX | SELL | 2024-02-12 | $346K | — | Filing → |